B · Normal
[USFDA approves new drug to treat metastatic pancreatic cancer] On August 27, the US Food and Drug Administration approved a new oral drug for the treatment of metastatic pancreatic cancer on the 26th, providing a new treatment option for some patients with advanced pancreatic cancer.
Comments